TN2009000469A1 - Organic compounds - Google Patents

Organic compounds

Info

Publication number: TN2009000469A1
Authority: TN; Tunisia
Prior art keywords: organic compounds; conditions; blockade; tautomers; solvates
Prior art date: 2007-05-07

Application number

TNP2009000469A

Other languages

English (en)

Inventor

Robin Alec Fairhurst

Rebecca Butler

Paul Oakley

Stephen Paul Collingwood

Nichola Smith

Emily Stanley

Perez Maria Ines Rodriguez

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-05-07

Filing date

2009-11-06

Publication date

2011-03-31

2009-11-06 Application filed by Novartis Ag filed Critical Novartis Ag

2011-03-31 Publication of TN2009000469A1 publication Critical patent/TN2009000469A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Oncology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

TNP2009000469A 2007-05-07 2009-11-06 Organic compounds TN2009000469A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07107654		2007-05-07
PCT/EP2008/055497 WO2008135557A1 (fr)	2007-05-07	2008-05-05	Composés organiques

Publications (1)

Publication Number	Publication Date
TN2009000469A1 true TN2009000469A1 (en)	2011-03-31

Family

ID=38581916

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TNP2009000469A TN2009000469A1 (en)	2007-05-07	2009-11-06	Organic compounds

Country Status (31)

Country	Link
US (1)	US8318935B2 (fr)
EP (2)	EP2155721B1 (fr)
JP (1)	JP5244904B2 (fr)
KR (1)	KR20100005730A (fr)
CN (1)	CN101687851B (fr)
AR (1)	AR066458A1 (fr)
AT (1)	ATE499363T1 (fr)
AU (1)	AU2008248598B2 (fr)
BR (1)	BRPI0811562A2 (fr)
CA (1)	CA2685546A1 (fr)
CL (1)	CL2008001301A1 (fr)
CO (1)	CO6290667A2 (fr)
CR (1)	CR11091A (fr)
DE (1)	DE602008005140D1 (fr)
EA (1)	EA200901489A1 (fr)
EC (1)	ECSP099718A (fr)
ES (1)	ES2361595T3 (fr)
GT (1)	GT200900289A (fr)
HN (1)	HN2009003214A (fr)
IL (1)	IL201828A0 (fr)
MA (1)	MA31400B1 (fr)
MX (1)	MX2009012077A (fr)
NZ (1)	NZ580737A (fr)
PE (1)	PE20090733A1 (fr)
PL (1)	PL2155721T3 (fr)
PT (1)	PT2155721E (fr)
SV (1)	SV2009003406A (fr)
TN (1)	TN2009000469A1 (fr)
TW (1)	TWI351402B (fr)
WO (1)	WO2008135557A1 (fr)
ZA (1)	ZA200907491B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6858615B2 (en)	2002-02-19	2005-02-22	Parion Sciences, Inc.	Phenyl guanidine sodium channel blockers
BRPI0907823A2 (pt)	2008-02-26	2015-07-21	Parion Sciences Inc	Bloqueadores poliaromáticos dos canais de sódio
KR20110085768A (ko)	2010-01-21	2011-07-27	삼성전자주식회사	Ｃｍｏｓ 이미지 센서, 상기 이미지 센서의 데이터 리드아웃 방법, 및 상기 이미지 센서를 포함하는 전자 시스템
US9050339B2 (en)	2010-09-17	2015-06-09	Novartis Ag	Pyrazine derivatives as ENaC blockers
US8372845B2 (en) *	2010-09-17	2013-02-12	Novartis Ag	Pyrazine derivatives as enac blockers
AR086745A1 (es)	2011-06-27	2014-01-22	Parion Sciences Inc	3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
NO2773633T3 (fr) *	2011-11-02	2017-12-30
EP2773624A1 (fr)	2011-11-02	2014-09-10	Boehringer Ingelheim International GmbH	Nouveau procédé pour la préparation d'acylguanidines et d'acylthiourées
US8859559B2 (en) *	2011-12-20	2014-10-14	Boehringer Ingelheim International Gmbh	Substituted pyrazines and their use in the treatment of disease
CN104520321A (zh)	2012-01-09	2015-04-15	斯克利普斯研究所	超长互补决定区及其用途
WO2013174757A1 (fr)	2012-05-25	2013-11-28	Boehringer Ingelheim International Gmbh	Amines tertiaires, médicaments contenant lesdites amines, leur utilisation et leurs procédés de préparation
JP6072920B2 (ja) *	2012-09-24	2017-02-01	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	複素環化合物、前記化合物を含む薬物、これらの使用及びこれらの調製方法
JP6302923B2 (ja)	2012-11-02	2018-03-28	バーテックスファーマシューティカルズインコーポレイテッドＶｅｒｔｅｘＰｈａｒｍａｃｅｕｔｉｃａｌｓＩｎｃｏｒｐｏｒａｔｅｄ	Ｃｆｔｒが媒介する疾患の処置のための医薬組成物
CN104995178B (zh)	2012-12-17	2018-06-26	帕里昂科学公司	3，5-二氨基-6-氯-n-(n-(4-苯基丁基)甲脒基)吡嗪-2-甲酰胺化合物
WO2014099676A1 (fr)	2012-12-17	2014-06-26	Parion Sciences, Inc.	Dérivés de chloro-pyrazine carboxamide utiles dans le traitement de maladies favorisées par une hydratation insuffisante des muqueuses
EP2991981B1 (fr)	2013-04-30	2017-03-01	Boehringer Ingelheim International GmbH	Composés de diaminopyrazine, médicaments contenant lesdits composés, leur utilisation et leurs procédés de préparation
CA2915633A1 (fr) *	2013-07-02	2015-01-08	The California Institute For Biomedical Research	Composes destines au traitement de la mucosviscidose
US9102633B2 (en)	2013-12-13	2015-08-11	Parion Sciences, Inc.	Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
UY36034A (es)	2014-03-18	2015-09-30	Astrazeneca Ab	Derivados de 3,5-diamino-6-cloro-pirazina-2-carboxamida y sales farmaceuticamente aceptables de estos
WO2015145353A1 (fr)	2014-03-27	2015-10-01	Novartis Ag	Dispersions d'huile-dans-l'eau solides séchées par pulvérisation pour l'inhalation de principes pharmaceutiques actifs
GB201412545D0 (en) *	2014-07-15	2014-08-27	Univ Manchester The And Manchester Metropolitan University	Enzymatic processes and uses
WO2016112120A1 (fr) *	2015-01-07	2016-07-14	The California Institute For Biomedical Research	Composés destinés au traitement de la mucosviscidose
US10155749B2 (en) *	2015-01-12	2018-12-18	Boehringer Ingelheim International Gmbh	Substituted benzimidazolium compounds useful in the treatment of respiratory diseases
EP3245201B1 (fr) *	2015-01-12	2019-06-19	Boehringer Ingelheim International GmbH	Composés de benzimidazolium substitués utiles pour le traitement de maladies respiratoires
JP6667537B2 (ja) *	2015-01-12	2020-03-18	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	呼吸器系疾患の治療に有用な四置換及び五置換ベンズイミダゾリウム化合物
US10291868B2 (en) *	2016-01-29	2019-05-14	SK Hynix Inc.	Image sensing device
GB201610854D0 (en)	2016-06-21	2016-08-03	Entpr Therapeutics Ltd	Compounds
GB201619694D0 (en)	2016-11-22	2017-01-04	Entpr Therapeutics Ltd	Compounds
EP3600440A1 (fr)	2017-03-20	2020-02-05	Sienna Biopharmaceuticals, Inc.	Conjugués d'exposition réduite modulant des cibles thérapeutiques
WO2018175302A1 (fr)	2017-03-20	2018-09-27	Sienna Biopharmaceuticals, Inc.	Conjugués polymères ciblant c-src à exposition réduite
GB201717051D0 (en)	2017-10-17	2017-11-29	Enterprise Therapeutics Ltd	Compounds
GB201808093D0 (en)	2018-05-18	2018-07-04	Enterprise Therapeutics Ltd	Compounds

Family Cites Families (117)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1219606A (en)	1968-07-15	1971-01-20	Rech S Et D Applic Scient Soge	Quinuclidinol derivatives and preparation thereof
US3544571A (en)	1968-09-04	1970-12-01	Merck & Co Inc	Process for making pyrazinoylthiourea compounds
US4246406A (en)	1979-03-27	1981-01-20	Merck & Co., Inc.	Heterocyclic substituted pyrazinoylguanidines
JPS6235216A (ja)	1985-08-09	1987-02-16	Noritoshi Nakabachi	不均質物質層の層厚非破壊測定方法および装置
GB8923590D0 (en)	1989-10-19	1989-12-06	Pfizer Ltd	Antimuscarinic bronchodilators
PT100441A (pt)	1991-05-02	1993-09-30	Smithkline Beecham Corp	Pirrolidinonas, seu processo de preparacao, composicoes farmaceuticas que as contem e uso
WO1993018007A1 (fr)	1992-03-13	1993-09-16	Tokyo Tanabe Company Limited	Nouveau derive de carbostyrile
WO1993019750A1 (fr)	1992-04-02	1993-10-14	Smithkline Beecham Corporation	Composes efficaces dans le traitement de maladies allergiques ou inflammatoires
CZ283425B6 (cs)	1992-04-02	1998-04-15	Smithkline Beecham Corporation	Fenylové deriváty a farmaceutické prostředky s jejich obsahem
MX9301942A (es)	1992-04-02	1994-08-31	Smithkline Beecham Corp	Derivados de ciclohexan-ilideno novedosos.
TW394760B (en) *	1993-09-07	2000-06-21	Hoffmann La Roche	Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
GB9622386D0 (en)	1996-10-28	1997-01-08	Sandoz Ltd	Organic compounds
US6166037A (en)	1997-08-28	2000-12-26	Merck & Co., Inc.	Pyrrolidine and piperidine modulators of chemokine receptor activity
AU9281298A (en)	1997-10-01	1999-04-23	Kyowa Hakko Kogyo Co. Ltd.	Benzodioxole derivatives
US6362371B1 (en)	1998-06-08	2002-03-26	Advanced Medicine, Inc.	β2- adrenergic receptor agonists
EP1098923B1 (fr)	1998-06-30	2004-11-17	Dow Global Technologies Inc.	Polymeres et leur procede de production
GB9913083D0 (en)	1999-06-04	1999-08-04	Novartis Ag	Organic compounds
AU780983B2 (en)	1999-05-04	2005-04-28	Schering Corporation	Piperidine derivatives useful as CCR5 antagonists
IL145741A0 (en)	1999-05-04	2002-07-25	Schering Corp	Piperazine derivatives useful as ccrs antagonists
ES2165768B1 (es)	1999-07-14	2003-04-01	Almirall Prodesfarma Sa	Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
ATE390414T1 (de) *	1999-07-19	2008-04-15	Univ North Carolina	Arzneimittelwirkstoffe mit zwei kovalent verknüpften wirkstoffgruppen (natriumkanalblocker/p2y2 rezeptor agonist) zur behandlung von schleimhäuten
NZ517166A (en)	1999-08-21	2004-01-30	Altana Pharma Ag	Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonists
OA11558A (en)	1999-12-08	2004-06-03	Advanced Medicine Inc	Beta 2-adrenergic receptor agonists.
WO2001083462A1 (fr)	2000-04-27	2001-11-08	Boehringer Ingelheim Pharma Kg	Nouveaux beta-mimetiques a action lente, leurs procedes de production et leur utilisation comme medicament
PL201530B1 (pl)	2000-06-27	2009-04-30	L V A T Lab Sa	Karbaminiany pochodne aryloalkiloamin i zastosowanie karbaminianów pochodnych aryloalkiloamin
GB0015876D0 (en)	2000-06-28	2000-08-23	Novartis Ag	Organic compounds
DE10038639A1 (de)	2000-07-28	2002-02-21	Schering Ag	Nichtsteroidale Entzündungshemmer
KR100889426B1 (ko)	2000-08-05	2009-03-23	글락소 그룹 리미티드	항염증제로서의 6.알파.,9.알파.-디플루오로-17.알파.-'(2-푸라닐카르복실)옥시-11.베타.-히드록시-16.알파.-메틸-3-옥소-안드로스트-1,4-디엔-17-카르보티오산 ｓ-플루오로메틸 에스테르
GB0028383D0 (en)	2000-11-21	2001-01-03	Novartis Ag	Organic compounds
CN1298717C (zh)	2000-12-22	2007-02-07	阿尔米雷尔普罗迪斯制药有限公司	奎宁环氨基甲酸酯衍生物及其作为m3拮抗剂的应用
CN1250545C (zh)	2000-12-28	2006-04-12	阿尔米雷尔普罗迪斯制药有限公司	新的奎宁环衍生物类及含有这类衍生物的药物组合物
GB0103630D0 (en)	2001-02-14	2001-03-28	Glaxo Group Ltd	Chemical compounds
ATE365720T1 (de)	2001-03-08	2007-07-15	Glaxo Group Ltd	Agonisten von beta-adrenorezeptoren
DE60224172T2 (de)	2001-03-22	2008-12-04	Glaxo Group Ltd., Greenford	Formanilid-derivative als beta2-adrenorezeptor-agonisten
NZ528888A (en)	2001-04-30	2005-10-28	Glaxo Group Ltd	Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
EP1395604B1 (fr)	2001-06-12	2008-06-25	Glaxo Group Limited	17 alpha esters heterocycliques anti-inflammatoires de derives de 17 beta carbothioate androstane
DK2327766T3 (en)	2001-06-21	2016-03-07	Basf Enzymes Llc	nitrilases
CN101701006B (zh)	2001-09-14	2014-03-05	葛兰素集团有限公司	治疗呼吸疾病的苯乙醇胺衍生物
JP2005512974A (ja)	2001-10-17	2005-05-12	ユセベソシエテアノニム	キヌクリジン誘導体、その調製方法、及びｍ２及び／又はｍ３ムスカリン受容体阻害剤としてのその使用
GB0125259D0 (en)	2001-10-20	2001-12-12	Glaxo Group Ltd	Novel compounds
AR037517A1 (es)	2001-11-05	2004-11-17	Novartis Ag	Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria
TWI249515B (en)	2001-11-13	2006-02-21	Theravance Inc	Aryl aniline beta2 adrenergic receptor agonists
US6653323B2 (en)	2001-11-13	2003-11-25	Theravance, Inc.	Aryl aniline β2 adrenergic receptor agonists
AU2002356759A1 (en)	2001-12-01	2003-06-17	Glaxo Group Limited	17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents
JP4505227B2 (ja)	2001-12-20	2010-07-21	キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ	１−アルキル−１−アゾニアビシクロ［２．２．２］オクタンカルバメート誘導体およびムスカリンレセプターアンタゴニストとしてのそれらの使用
AU2003202044A1 (en)	2002-01-15	2003-09-09	Glaxo Group Limited	17.alpha-cycloalkyl/cycloylkenyl esters of alkyl-or haloalkyl-androst-4-en-3-on-11.beta.,17.alpha.-diol 17.beta.-carboxylates as anti-inflammatory agents
WO2003062259A2 (fr)	2002-01-21	2003-07-31	Glaxo Group Limited	Nouveaux composes
GB0202216D0 (en)	2002-01-31	2002-03-20	Glaxo Group Ltd	Novel compounds
GB0204719D0 (en)	2002-02-28	2002-04-17	Glaxo Group Ltd	Medicinal compounds
CA2477764A1 (fr)	2002-03-26	2003-10-09	Boehringer Ingelheim Pharmaceuticals, Inc.	Mimetiques du glucocorticoide, procedes de fabrication de ces mimetiques, compositions pharmaceutiques et leurs utilisations
DE60318188T2 (de)	2002-03-26	2008-12-11	Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield	Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
CA2481320A1 (fr)	2002-04-11	2003-10-23	Merck & Co., Inc.	Derives de 1h-benzo[f]indazol-5-yl utilises en tant que modulateurs selectifs du recepteur glucocorticoide
ES2206021B1 (es)	2002-04-16	2005-08-01	Almirall Prodesfarma, S.A.	Nuevos derivados de pirrolidinio.
EP1497261B1 (fr)	2002-04-25	2007-12-19	Glaxo Group Limited	Derives de la phenethanolamine
AU2003239880A1 (en)	2002-05-28	2003-12-12	Theravance, Inc.	ALKOXY ARYL Beta2 ADRENERGIC RECEPTOR AGONISTS
US7186864B2 (en)	2002-05-29	2007-03-06	Boehringer Ingelheim Pharmaceuticals, Inc.	Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
ES2201907B1 (es)	2002-05-29	2005-06-01	Almirall Prodesfarma, S.A.	Nuevos derivados de indolilpiperidina como potentes agentes antihistaminicos y antialergicos.
DE10224888A1 (de)	2002-06-05	2003-12-24	Merck Patent Gmbh	Pyridazinderivate
US7074806B2 (en)	2002-06-06	2006-07-11	Boehringer Ingelheim Pharmaceuticals, Inc.	Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
DE10225574A1 (de)	2002-06-10	2003-12-18	Merck Patent Gmbh	Aryloxime
DE10227269A1 (de)	2002-06-19	2004-01-08	Merck Patent Gmbh	Thiazolderivate
ATE356808T1 (de)	2002-06-25	2007-04-15	Merck Frosst Canada Ltd	8-(biaryl)chinolin-pde4-inhibitoren
EP1519922A1 (fr)	2002-07-02	2005-04-06	Merck Frosst Canada & Co.	Ethane pyridone a substitution diaryle, inhibiteurs d'enzyme pde4
ES2204295B1 (es)	2002-07-02	2005-08-01	Almirall Prodesfarma, S.A.	Nuevos derivados de quinuclidina-amida.
DK1521733T3 (da)	2002-07-08	2014-10-13	Pfizer Prod Inc	Modulatorer af glucocorticoid receptoren
GB0217225D0 (en)	2002-07-25	2002-09-04	Glaxo Group Ltd	Medicinal compounds
AR040962A1 (es)	2002-08-09	2005-04-27	Novartis Ag	Compuestos derivados de tiazol 1,3-2-ona, composicion farmaceutica y proceso de preparacion del compuesto
EP1537100B1 (fr)	2002-08-10	2007-04-25	ALTANA Pharma AG	Piperidine-phthalazones a substitution pyrrolidinedione utilises comme inhibiteurs de la phosphodiesterase-4 (pde4)
AU2003260371A1 (en)	2002-08-10	2004-03-11	Altana Pharma Ag	Piperidine-n-oxide-derivatives
HRP20050199A2 (hr)	2002-08-10	2006-04-30	Altana Pharma Ag	Novi derivati piridazinona
AU2003255376A1 (en)	2002-08-10	2004-03-11	Altana Pharma Ag	Piperidine-derivatives as pde4 inhibitors
WO2004018465A2 (fr)	2002-08-17	2004-03-04	Altana Pharma Ag	Nouvelles benzonaphtyridines
US20060116518A1 (en)	2002-08-17	2006-06-01	Altana Pharma Ag	Novel phenanthridines
SE0202483D0 (sv)	2002-08-21	2002-08-21	Astrazeneca Ab	Chemical compounds
WO2004018429A2 (fr)	2002-08-21	2004-03-04	Boehringer Ingelheim Pharmaceuticals, Inc.	Composes mimetiques de glucocorticoide, leurs procedes de fabrication, compositions pharmaceutiques, et leurs utilisations
WO2004018422A1 (fr)	2002-08-23	2004-03-04	Ranbaxy Laboratories Limited	Derives d'azabicyclo(3.1.0)hexanes 3,6-disubstitues contenant fluoro et sulfonylamino, utilises comme antagonistes des recepteurs de muscarine
BR0313923A (pt)	2002-08-29	2005-07-12	Boehringer Ingelheim Pharma	Derivados de 3-(sulfonamidoetil)-indol para uso como miméticos de glicocorticóide no tratamento de doenças inflamatórias, alérgicas e proliferativas
CA2495827C (fr)	2002-08-29	2012-05-08	Altana Pharma Ag	2-hydroxy-6-phenylphenanthridines utilisees comme inhibiteurs de pde-4
ATE353217T1 (de)	2002-08-29	2007-02-15	Altana Pharma Ag	3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
GB0220730D0 (en)	2002-09-06	2002-10-16	Glaxo Group Ltd	Medicinal compounds
JP2006096662A (ja)	2002-09-18	2006-04-13	Sumitomo Pharmaceut Co Ltd	新規６−置換ウラシル誘導体及びアレルギー性疾患の治療剤
TW200413372A (en)	2002-09-18	2004-08-01	Ono Pharmaceutical Co	Derivatives of triazaspiro [5.5] undecane and medicants using such derivatives as effective ingredient
WO2004026248A2 (fr)	2002-09-20	2004-04-01	Merck & Co., Inc.	Derives d'octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide en tant que modulateurs selectifs de recepteur glucocorticoide
JP2004107299A (ja)	2002-09-20	2004-04-08	Japan Energy Corp	新規１−置換ウラシル誘導体及びアレルギー性疾患の治療剤
DE10246374A1 (de)	2002-10-04	2004-04-15	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1440966A1 (fr)	2003-01-10	2004-07-28	Pfizer Limited	Dérivés d'indole utilisables pour traiter des maladies
JP4490911B2 (ja)	2002-10-11	2010-06-30	ファイザー・インク	β−２アゴニストとしてのインドール誘導体
DE60315492T2 (de)	2002-10-22	2008-04-24	Glaxo Group Ltd., Greenford	Medizinisch verwendbare arylethanolamin verbindungen
WO2004037805A1 (fr)	2002-10-23	2004-05-06	Glenmark Pharmaceuticals Ltd.	Nouveaux composes tricycliques utiles pour traiter les troubles inflammatoires et allergiques, procede de preparation de ces composes et compositions pharmaceutiques les contenant
GB0225030D0 (en)	2002-10-28	2002-12-04	Glaxo Group Ltd	Medicinal compounds
DK1556342T3 (da)	2002-10-28	2008-07-21	Glaxo Group Ltd	Phenethanolaminderivat til behandling af respiratoriske sygdomme
GB0225287D0 (en)	2002-10-30	2002-12-11	Glaxo Group Ltd	Novel compounds
GB0225540D0 (en)	2002-11-01	2002-12-11	Glaxo Group Ltd	Medicinal compounds
GB0225535D0 (en)	2002-11-01	2002-12-11	Glaxo Group Ltd	Medicinal compounds
DE10253282A1 (de)	2002-11-15	2004-05-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
DE10253220A1 (de)	2002-11-15	2004-05-27	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Neue Dihydroxy-Methyl-Phenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10253426B4 (de)	2002-11-15	2005-09-22	Elbion Ag	Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
DE10261874A1 (de)	2002-12-20	2004-07-08	Schering Ag	Nichtsteroidale Entzündungshemmer
JP4606408B2 (ja)	2003-01-21	2011-01-05	メルク・シャープ・エンド・ドーム・コーポレイション	選択的グルココルチコイド受容体調節物質としての１７−カルバモイルオキシコルチゾル誘導体
PE20040950A1 (es)	2003-02-14	2005-01-01	Theravance Inc	DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
US20050113423A1 (en)	2003-03-12	2005-05-26	Vangoor Frederick F.	Modulators of ATP-binding cassette transporters
EP1460064A1 (fr)	2003-03-14	2004-09-22	Pfizer Limited	Derivés de Indole-2-carboxamide comme beta-2 agonistes
WO2004110352A2 (fr)	2003-05-16	2004-12-23	The Regents Of The University Of California	Composes accroissant le transport d'ions par des cftr de mutants, et leurs utilisations
GB0312832D0 (en)	2003-06-04	2003-07-09	Pfizer Ltd	2-amino-pyridine derivatives useful for the treatment of diseases
WO2004111014A1 (fr)	2003-06-06	2004-12-23	Vertex Pharmaceuticals Incorporated	Derives de pyrimidne utilises en tant que modulateurs de transporteurs de cassette de liaison a l'atp
AU2004245174A1 (en)	2003-06-10	2004-12-16	Ace Biosciences A/S	Extracellular Aspergillus polypeptides
CA2534569A1 (fr) *	2003-08-18	2005-02-24	Parion Sciences, Inc.	Bloqueurs du canal sodique a pyrazinoyl-guanidine cyclique
CA2534568A1 (fr) *	2003-08-18	2005-03-24	Parion Sciences, Inc.	Bloqueurs du canal sodique a base de pyrazinoylguanidine alaphatique
US7973169B2 (en)	2003-09-06	2011-07-05	Vertex Pharmaceuticals Incorporated	Modulators of ATP-Binding Cassette transporters
JP2007509044A (ja)	2003-10-08	2007-04-12	バーテックス　ファーマシューティカルズ　インコーポレイテッド	シクロアルキルピラニル基を含むａｔｐ結合カセットトランスポーターのモジュレータ
US7541466B2 (en)	2003-12-23	2009-06-02	Genzyme Corporation	Tetrahydroisoquinoline derivatives for treating protein trafficking diseases
JP4960708B2 (ja)	2004-01-30	2012-06-27	バーテックスファーマシューティカルズインコーポレイテッド	Ａｔｐ結合カセットトランスポーターのモジュレーター
AU2005251745A1 (en)	2004-06-04	2005-12-22	The Regents Of The University Of California	Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof
WO2006099256A2 (fr)	2005-03-11	2006-09-21	Vertex Pharmaceuticals Incorporated	Modulateurs de transporteurs de cassette de liaison a l'atp
RU2007138584A (ru)	2005-03-18	2009-04-27	Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния (Us)	Соединения, обладающие активностью для коррекции процессинга мутантного cftr, и их применение
AU2006251624A1 (en)	2005-05-24	2006-11-30	Vertex Pharmaceuticals Incorporated	Modulators of ATP-Binding cassette transporters
JP5143738B2 (ja)	2005-08-11	2013-02-13	バーテックスファーマシューティカルズインコーポレイテッド	嚢胞性線維症膜コンダクタンス制御因子の調節物質

2008
- 2008-05-05 ES ES08759419T patent/ES2361595T3/es active Active
- 2008-05-05 PT PT08759419T patent/PT2155721E/pt unknown
- 2008-05-05 CA CA002685546A patent/CA2685546A1/fr not_active Abandoned
- 2008-05-05 EP EP08759419A patent/EP2155721B1/fr active Active
- 2008-05-05 AT AT08759419T patent/ATE499363T1/de active
- 2008-05-05 PE PE2008000782A patent/PE20090733A1/es not_active Application Discontinuation
- 2008-05-05 EP EP11152559A patent/EP2332933A1/fr not_active Withdrawn
- 2008-05-05 AU AU2008248598A patent/AU2008248598B2/en not_active Ceased
- 2008-05-05 NZ NZ580737A patent/NZ580737A/en not_active IP Right Cessation
- 2008-05-05 BR BRPI0811562-1A2A patent/BRPI0811562A2/pt not_active IP Right Cessation
- 2008-05-05 WO PCT/EP2008/055497 patent/WO2008135557A1/fr not_active Ceased
- 2008-05-05 JP JP2010506915A patent/JP5244904B2/ja not_active Expired - Fee Related
- 2008-05-05 KR KR1020097025395A patent/KR20100005730A/ko not_active Abandoned
- 2008-05-05 US US12/451,152 patent/US8318935B2/en not_active Expired - Fee Related
- 2008-05-05 CN CN2008800226814A patent/CN101687851B/zh not_active Expired - Fee Related
- 2008-05-05 PL PL08759419T patent/PL2155721T3/pl unknown
- 2008-05-05 DE DE602008005140T patent/DE602008005140D1/de active Active
- 2008-05-05 MX MX2009012077A patent/MX2009012077A/es active IP Right Grant
- 2008-05-05 EA EA200901489A patent/EA200901489A1/ru unknown
- 2008-05-06 CL CL2008001301A patent/CL2008001301A1/es unknown
- 2008-05-06 TW TW097116687A patent/TWI351402B/zh not_active IP Right Cessation
- 2008-05-06 AR ARP080101913A patent/AR066458A1/es not_active Application Discontinuation
2009
- 2009-10-26 ZA ZA200907491A patent/ZA200907491B/xx unknown
- 2009-10-29 IL IL201828A patent/IL201828A0/en unknown
- 2009-11-04 CR CR11091A patent/CR11091A/es unknown
- 2009-11-05 GT GT200900289A patent/GT200900289A/es unknown
- 2009-11-06 CO CO09125992A patent/CO6290667A2/es not_active Application Discontinuation
- 2009-11-06 HN HN2009003214A patent/HN2009003214A/es unknown
- 2009-11-06 EC EC2009009718A patent/ECSP099718A/es unknown
- 2009-11-06 SV SV2009003406A patent/SV2009003406A/es active IP Right Grant
- 2009-11-06 TN TNP2009000469A patent/TN2009000469A1/fr unknown
- 2009-11-30 MA MA32385A patent/MA31400B1/fr unknown

Also Published As

Publication number	Publication date
MA31400B1 (fr)	2010-05-03
JP2010526118A (ja)	2010-07-29
WO2008135557A1 (fr)	2008-11-13
NZ580737A (en)	2012-03-30
US8318935B2 (en)	2012-11-27
ZA200907491B (en)	2010-07-28
EA200901489A1 (ru)	2010-04-30
PT2155721E (pt)	2011-05-09
MX2009012077A (es)	2009-11-19
SV2009003406A (es)	2010-01-12
DE602008005140D1 (de)	2011-04-07
TW200902517A (en)	2009-01-16
HK1141285A1 (en)	2010-11-05
CN101687851B (zh)	2013-02-27
PE20090733A1 (es)	2009-07-17
AU2008248598A1 (en)	2008-11-13
EP2155721B1 (fr)	2011-02-23
CA2685546A1 (fr)	2008-11-13
AU2008248598B2 (en)	2011-11-17
IL201828A0 (en)	2010-06-16
CL2008001301A1 (es)	2008-12-19
KR20100005730A (ko)	2010-01-15
ECSP099718A (es)	2009-12-28
AR066458A1 (es)	2009-08-19
US20100105660A1 (en)	2010-04-29
CR11091A (es)	2009-12-17
ATE499363T1 (de)	2011-03-15
EP2155721A1 (fr)	2010-02-24
ES2361595T3 (es)	2011-06-20
PL2155721T3 (pl)	2011-07-29
CN101687851A (zh)	2010-03-31
CO6290667A2 (es)	2011-06-20
JP5244904B2 (ja)	2013-07-24
TWI351402B (en)	2011-11-01
BRPI0811562A2 (pt)	2014-12-09
HN2009003214A (es)	2012-03-05
GT200900289A (es)	2010-05-21
EP2332933A1 (fr)	2011-06-15

Publication	Publication Date	Title
TN2009000469A1 (en)	2011-03-31	Organic compounds
TW200745086A (en)	2007-12-16	Organic compounds
PH12022551574A1 (en)	2024-02-26	Egfr inhibitors
IN2012DN00999A (fr)	2015-04-10
MX2009012847A (es)	2009-12-08	Analogos dipeptidicos como inhibidores de factores de coagulacion.
MX2012010918A (es)	2013-01-18	Analogos para el tratamiento o prevencion de infecciones por flavivirus.
UA94833C2 (en)	2011-06-10	Substituted bicyclolactams
MY146924A (en)	2012-10-15	Substituted imidazoheterocycles
MX2010013768A (es)	2011-03-03	Fosfatos ciclicos de nucleosidos.
MX2011011136A (es)	2011-11-18	Eteres diarilicos.
ZA202201503B (en)	2023-11-29	Urea compound for antagonizing lpa1 receptor
SG178952A1 (en)	2012-04-27	Chemical compounds
MX2009012418A (es)	2010-03-10	Derivados de quinazolin-oxima como inhibidores de hsp90.
MX2012007420A (es)	2012-07-23	Analogos para el tratamiento o prevencion de infecciones de flavivirus.
EA201170617A1 (ru)	2011-12-30	Пиразолиламинопиридины в качестве ингибиторов fak
MX2009008275A (es)	2009-08-12	Formas polimorficas de un inhibidor macrociclico del virus de la hepatitis c.
MX2012002752A (es)	2012-04-19	Compuestos de heteroarilo como inhibidores de cinasa.
MX2009008540A (es)	2009-08-18	Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina.
MX2024000230A (es)	2024-04-01	Inhibidores de cdk2.
MX2011011776A (es)	2012-08-03	Nuevos profarmacos de triptolite.
MX2009012125A (es)	2010-02-18	Compuestos terapeuticos.
IN2012DN01273A (fr)	2015-05-15
MX2010008226A (es)	2010-10-25	Derivados de difluorobifenilamida para el tratamiento de hipertension ocular.
CR20240014A (es)	2024-05-07	Pirimidinil-pirazoles sustituidos como inhibidores de cdk2
GEP20156244B (en)	2015-02-10	New tertiary 8-hydroxyquinoline-7- carboxamide derivatives and usage thereof